Bulk Orders 20+ vials
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
GLP Collection
Metatrutide (GLP-4) is a custom Disguised Alpha research peptide blend containing 10 mg GLP-3 RT and 2 mg PEG-MGF per vial, for 12 mg total. Review the Metatrutide formula breakdown, research references and certificate of analysis for the assigned shipping batch.
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkShipping batch 335XA
Open the certificate matched to this shipping batch.
Verified test results
Each batch is analyzed by Chromate, an independent third-party laboratory, before release. Below is the report for lot 335XA, summarized from the certificate the lab published.
This lot ships under its own published certificate. Open any certificate below, exactly as the lab released it.
Side by side
Technical specifications
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Lyophilized research material
Metatrutide (GLP-4) is Disguised Alpha’s custom research peptide blend containing 10 mg GLP-3 RT plus 2 mg PEG-MGF per vial, for 12 mg total labeled material. This page brings together the Metatrutide ingredient breakdown, component research references and batch-specific certificate of analysis (COA). The product is supplied as lyophilized material for laboratory research only.
A house research blend combining a triple-receptor peptide listing with PEG-MGF. Its name does not establish a fourth GLP receptor.
The catalog specifies 10 mg GLP-3 RT plus 2 mg PEG-MGF. Metatrutide is used here as a DA blend name; the supplied mixture is not a single established four-receptor drug.
The cited receptor study supports retatrutide component context only. No primary study of this exact house blend was identified in the reviewed sources.
Published findings describe the materials and conditions in the cited studies. Receptor or cell-pathway evidence does not establish safety or efficacy of this finished research product. Match the supplied identity and format to the current label and batch documentation.
GLP4-Metatrutide is a custom Disguised Alpha research formula. It contains 10MG GLP-3 RT and 2MG PEG-MGF. Advanced lab studies cover multi-incretin pathway research and metabolic signaling. Other areas include tissue-response models and growth-factor pathway research. Studies also cover body-composition pathways, cellular repair signaling, and metabolic adaptation models.
This custom Disguised Alpha formula is made in-house. It links metabolic signaling research with tissue-response research. GLP4-Metatrutide combines a GLP-3 RT style multi-incretin pathway profile with PEG-MGF, a growth-factor-associated peptide studied in tissue remodeling and cellular response models.
GLP4-Metatrutide is an in-house research blend for advanced models. These examine the overlap of incretin signaling and metabolic adaptation. They also examine tissue-response biology and growth-factor-associated cellular pathways.
| GLP-3 RT | 10MG |
|---|---|
| PEG-MGF | 2MG |
| Formula Type | Custom in-house Disguised Alpha research blend |
GLP-3 RT is studied in models of GLP-1, GIP, and glucagon-related signaling. Other models cover metabolic pathways.
PEG-MGF is studied in tissue-response signaling and muscle-cell pathway models. Other work covers remodeling biology.
Disguised Alpha designed this for researchers studying the overlap of metabolic and tissue-response pathway systems.
GLP4-Metatrutide is intended for advanced research models of metabolic signaling and incretin pathway activity. These models evaluate tissue-response biology and growth-factor-associated mechanisms together. GLP-3 RT is studied in multi-incretin signaling across GLP-1, GIP, and glucagon-related pathway systems. PEG-MGF is studied in mechanical stress response and cellular repair signaling. Other models cover tissue remodeling and growth-factor pathway activity.
This blend gives research a framework to study possible links between metabolic adaptation and tissue-response pathways. The work uses controlled laboratory models. It is an in-house research formula for deeper pathway study, rather than a simple GLP product.
GLP4-Metatrutide is for researchers comparing GLP1, GLP2, GLP3, and custom multi-pathway formulas. It provides a distinct research model that extends beyond incretin signaling alone.
GLP-4 Metatrutide research guide
Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.
Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.
Metatrutide is the Disguised Alpha blend name for GLP-4, a two-component research formulation of GLP-3 RT and PEG-MGF. It describes this supplied blend, not a single established four-receptor drug.
In the Disguised Alpha catalog, Metatrutide, GLP-4 Metatrutide and GLP4-Metatrutide refer to this same research blend. Verify the formula and lot documentation when comparing products, because a catalog name alone does not establish matching composition.
No. GLP-3 RT is one component of this formula. The Metatrutide peptide blend also contains PEG-MGF. Research on an individual component does not establish the properties, interactions or performance of the combined formulation.
The 12 mg listing is the combined labeled material per vial: 10 mg GLP-3 RT plus 2 mg PEG-MGF. It is not a concentration or administration instruction. A prepared solution has its own concentration and stability requirements. Verify the exact selected option and shipping lot.
Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.
We share visit and purchase data with advertising partners to measure and show ads. Some US state laws, including California's, call that a sale or sharing of personal information. You can turn it off for this browser.
Ad sharing is on in this browser.
Saved in this browser only. For your account or other devices, email support@disguisedalpha.com. Privacy Policy